Nanoscale Horiz., 2024, Accepted Manuscript
DOI: 10.1039/D4NH00281D, Communication
DOI: 10.1039/D4NH00281D, Communication
Open Access
  This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Hu Xing, Yiting Zhang, Runliu Li, Hans-Maximilian Ruzicka, Christopher Hain, Jakob Andersson, Anil Bozdogan, Marius Henkel, Uwe Knippschild, Roger Hasler, Christoph Kleber, Wolfgang Knoll, Ann-Kathrin Kissmann, Frank Rosenau
The use of health-relevant bacteria originating from human microbiomes for the control or therapy of diseases including neurodegenerative disorders or diabetes is currently arising as the next “big thing” in...
The content of this RSS Feed (c) The Royal Society of Chemistry
The use of health-relevant bacteria originating from human microbiomes for the control or therapy of diseases including neurodegenerative disorders or diabetes is currently arising as the next “big thing” in...
The content of this RSS Feed (c) The Royal Society of Chemistry